Toggle navigation
Home
Search
Services
Blog
Contact
About
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kmt Hepatech, Inc., Edmonton, AB, Canada
Search grants from Kmt Hepatech, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PPHF 2014 Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) - Building and Strengthening Epidemiology, Laboratory and Health Information Systems Capacity
Theoretical Studies of Protein Folding
Ontogeny of Neuroadaptive Responses to Psychostimulants
Cloning and Characterization of Human Chromosome 3p Tumor Suppressor Genes
LSC: The Escherichia Coli Genetic Stock Center
Recently added grants:
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
Uz-Ucsf Ctu
AKI-Sapere- a novel prognostic of Acute Kidney Injury due to cardiac surgery
Rational design and B cell responses of HIV epitope vaccines
Viral and Host Determinants of Chikungunya Virus Dissemination
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
272201000016I-0-27200001-1
Application #
8539576
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$1,292,503
Indirect Cost
Institution
Name
Kmt Hepatech, Inc.
Department
Type
DUNS #
202499542
City
Edmonton
State
AB
Country
Canada
Zip Code
76 2-E1
Related projects
NIH 2012
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
/ Kmt Hepatech, Inc.
$1,292,503
NIH 2011
N01 AI
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
Kneteman, Norman / Kmt Hepatech, Inc.
$1,260,145
NIH 2010
N01 AI
Animal Models of Infectious Diseases
/
$50,000
Comments
Be the first to comment on this grant